Atlas Trials

Impact of Tapering Immunosuppressants on Maintaining Minimal Disease Activity in Adult Subjects With Psoriatic Arthritis

Clinical trial NCT04610476 · UNKNOWN

Trial details

NCT number
NCT04610476
Sponsor
University of Erlangen-Nürnberg Medical School
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
Psoriatic ArthritisWithdrawalReduction
Start date
2020-10-19
Primary completion
2024-10-19
Enrollment
270

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.